Literature DB >> 19280360

Impact of acute kidney injury on metformin-associated lactic acidosis.

Yao-Ko Wen1.   

Abstract

OBJECTIVES: Metformin has been shown to reduce diabetic complications in overweight patients, and is increasingly used to treat this condition. However, this agent is associated with a rare but serious risk of lactic acidosis.
METHODS: From January 2004 to November 2008, 11 cases of metformin-associated lactic acidosis were seen at a medical center in Taiwan. The patients' records were retrospectively reviewed with respect to clinical presentation, biochemical data, therapeutic strategies, and outcomes.
RESULTS: Ten out of 11 patients with acute kidney injury were enrolled in this study. From their pre-existing states, these patients would have been considered at low risk of developing lactic acidosis. However, all of them had acute intercurrent conditions that might compromise renal function. Among them, six patients were ventilated and five patients had severe hypotension with vasoactive support. Nine patients received renal replacement therapy to clear the acidosis and treat the renal failure. All but one of our patients survived. Recovery of renal function was the general rule in survivors.
CONCLUSIONS: Metformin-associated lactic acidosis is commonly accompanied with acute kidney injury. In spite of the severity of their illness, the outcome is favorable with intensive support of the cardiovascular, respiratory, and renal systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280360     DOI: 10.1007/s11255-009-9549-6

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

Review 1.  The phantom of lactic acidosis due to metformin in patients with diabetes.

Authors:  Robert I Misbin
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

2.  Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.

Authors:  Jaume Almirall; Meritxell Bricullé; José-Miguel Gonzalez-Clemente
Journal:  Nephrol Dial Transplant       Date:  2008-04-03       Impact factor: 5.992

3.  Lactic acidosis in patients with diabetes treated with metformin.

Authors:  R I Misbin; L Green; B V Stadel; J L Gueriguian; A Gubbi; G A Fleming
Journal:  N Engl J Med       Date:  1998-01-22       Impact factor: 91.245

4.  Metformin and antihypertensive therapy with drugs blocking the renin angiotensin system, a cause of concern?

Authors:  H Gudmundsdottir; H Aksnes; K Heldal; A Krogh; S Froyshov; N Rudberg; I Os
Journal:  Clin Nephrol       Date:  2006-11       Impact factor: 0.975

5.  Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination.

Authors:  J D Lalau; M Andrejak; P Morinière; B Coevoet; X Debussche; P F Westeel; A Fournier; J Quichaud
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1989-06

6.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

7.  Metformin-associated lactic acidosis and acute renal failure in a type 2 diabetic patient.

Authors:  Chen-Kuo Chu; Yao-Tien Chang; Bor-Jen Lee; Sung-Yuan Hu; Wei-Hsiung Hu; Dar-Yu Yang
Journal:  J Chin Med Assoc       Date:  2003-08       Impact factor: 2.743

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Lactic acidosis rates in type 2 diabetes.

Authors:  J B Brown; K Pedula; J Barzilay; M K Herson; P Latare
Journal:  Diabetes Care       Date:  1998-10       Impact factor: 19.112

10.  Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunction.

Authors:  Pat Audia; Donald A Feinfeld; Alan Dubrow; James F Winchester
Journal:  Clin Toxicol (Phila)       Date:  2008-02       Impact factor: 4.467

View more
  5 in total

Review 1.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

Authors:  Silvio E Inzucchi; Kasia J Lipska; Helen Mayo; Clifford J Bailey; Darren K McGuire
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

2.  Rapid recovery from acute kidney injury in a patient with metformin-associated lactic acidosis and hypothermia.

Authors:  Esmat Mustafa; Liwen Lai; Yeong-Hau H Lien
Journal:  Am J Med       Date:  2012-02       Impact factor: 4.965

Review 3.  Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns.

Authors:  Eva C Diaz; David N Herndon; Craig Porter; Labros S Sidossis; Oscar E Suman; Elisabet Børsheim
Journal:  Burns       Date:  2014-11-16       Impact factor: 2.744

Review 4.  Acute kidney injury in the elderly population.

Authors:  Rahmi Yilmaz; Yunus Erdem
Journal:  Int Urol Nephrol       Date:  2009-08-26       Impact factor: 2.370

5.  Updated review: improved glycemic control with repaglinide-metformin in fixed combination for patients with type 2 diabetes.

Authors:  John W Richard; Philip Raskin
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2011-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.